for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Bayer AG

BAYGN.DE

Latest Trade

50.51EUR

Change

0.22(+0.44%)

Volume

1,800,973

Today's Range

50.26

 - 

50.83

52 Week Range

39.91

 - 

59.55

As of on the XETRA ∙ Minimum 15 minute delay

Pricing

Previous Close
50.29
Open
50.50
Volume
1,800,973
3M AVG Volume
58.61
Today's High
50.83
Today's Low
50.26
52 Week High
59.55
52 Week Low
39.91
Shares Out (MIL)
982.42
Market Cap (MIL)
49,406.11
Forward P/E
8.56
Dividend (Yield %)
3.98

Latest Developments

More

France's CNIL data privacy watchdog fines Monsanto 400,000 euros

Bayer's Chronic Heart Failure Treatment Verquvo Approved In EU

Bayer AG U.S. FDA Approves Finerenone For Treatment Of Patients With Chronic Kidney Disease Associated With Type 2 Diabetes

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Bayer AG

Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and non

Industry

Major Drugs

Contact Info

Kaiser-Wilhelm-Allee 1

51373

Germany

+49.214.301

https://www.bayer.de/

Executive Leadership

Norbert Winkeljohann

Chairman of the Supervisory Board

Werner Baumann

Chairman of the Management Board, Chief Executive Officer

Oliver Zuehlke

Independent Vice Chairman of the Supervisory Board

Wolfgang U. Nickl

Chief Financial Officer, Member of the Management Board

Liam Condon

Member of the Management Board, Head of the Crop Science Division, Animal Health Business Unit

Key Stats

2.17 mean rating - 30 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2018

39.6K

2019

43.5K

2020

41.4K

2021(E)

41.4K
EPS (EUR)

2018

5.940

2019

6.400

2020

6.390

2021(E)

5.876
Price To Earnings (TTM)
--
Price To Sales (TTM)
1.21
Price To Book (MRQ)
1.43
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
123.93
LT Debt To Equity (MRQ)
109.63
Return on Investment (TTM)
-15.41
Return on Equity (TTM)
-12.15

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up